1. Home
  2. POST vs GRFS Comparison

POST vs GRFS Comparison

Compare POST & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Post Holdings Inc.

POST

Post Holdings Inc.

HOLD

Current Price

$88.63

Market Cap

5.0B

ML Signal

HOLD

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$7.20

Market Cap

4.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
POST
GRFS
Founded
1895
1940
Country
United States
Spain
Employees
N/A
25247
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0B
4.9B
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
POST
GRFS
Price
$88.63
$7.20
Analyst Decision
Buy
Hold
Analyst Count
7
2
Target Price
$124.50
$10.15
AVG Volume (30 Days)
789.9K
718.4K
Earning Date
05-07-2026
07-28-2022
Dividend Yield
N/A
1.80%
EPS Growth
N/A
N/A
EPS
3.28
N/A
Revenue
$8,158,100,000.00
N/A
Revenue This Year
$4.93
$4.49
Revenue Next Year
$0.47
$6.42
P/E Ratio
$26.98
$18.67
Revenue Growth
2.97
N/A
52 Week Low
$86.37
$6.96
52 Week High
$116.35
$11.14

Technical Indicators

Market Signals
Indicator
POST
GRFS
Relative Strength Index (RSI) 42.31 40.35
Support Level $86.61 N/A
Resistance Level $108.07 $7.73
Average True Range (ATR) 2.71 0.16
MACD 0.31 0.00
Stochastic Oscillator 29.94 34.06

Price Performance

Historical Comparison
POST
GRFS

About POST Post Holdings Inc.

Post Holdings Inc. is a consumer packaged goods holding company with products sold through grocery, club, and drug stores, mass merchandisers, foodservice, food ingredient, and eCommerce. It operates through four reportable segments: Post Consumer Brands, focused on North American ready-to-eat cereal and granola, pet food, and nut butters; Weetabix, focused on U.K. ready-to-eat cereal, muesli, and protein-based shakes; Foodservice, focused on egg and potato products; and Refrigerated Retail, focused on side dish, egg, cheese, and sausage products. Products are sold across channels, including retailers, wholesalers, convenience stores, pet supply retailers, drug store customers, military and national restaurant chains, with revenues largely generated in the U.S.

About GRFS Grifols S.A.

Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.

Share on Social Networks: